SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-23-036607
Filing Date
2023-03-24
Accepted
2023-03-24 16:05:33
Documents
12
Period of Report
2023-01-17
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2310372d2_8ka.htm   iXBRL 8-K/A 26191
  Complete submission text file 0001104659-23-036607.txt   201124

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA lptx-20230117.xsd EX-101.SCH 3028
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE lptx-20230117_lab.xml EX-101.LAB 34477
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lptx-20230117_pre.xml EX-101.PRE 22592
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2310372d2_8ka_htm.xml XML 3711
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37990 | Film No.: 23759883
SIC: 2834 Pharmaceutical Preparations